Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the first quarter 2026 after market close on Thursday, May 7, 2026. Company...
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know
1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds
Why Is Guardant Health (GH) Stock Soaring Today
This milestone underscores the power of Guardant Health’s InfinityAI platform and real-world data to enable innovative evidence generation in rare biomarker-defined populations
Why Guardant Health (GH) Stock Is Falling Today
3 Growth Stocks We Think Twice About
Combination of high quality, variable-rich, curated EHR data with genomics enhances understanding of the patient journey and aids in therapy development
3 Reasons to Avoid GH and 1 Stock to Buy Instead
Guardant Reveal demonstrates expanded utility in identifying new, primary cancers during minimal residual disease (MRD) monitoring Studies show strong...